Yan Zhang

Yan Zhang

Auto-generated profile, based on publicly available information

Yan Zhang

The Ohio State University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2015 in Nature
Verified
Journal Article
Open access
PDF file
PSPeter H. Sudmant
Peter H. Sudmant
TRTobias Rausch
Tobias Rausch
EGEugene J. Gardner
Eugene J. Gardner
RHRobert E. Handsaker
Robert E. Handsaker
AAAlexij Abyzov
Alexij Abyzov
JKJan O. Korbel
Jan O. Korbel
Structural variants are implicated in numerous diseases and make up the majority of varying nucleotides among human genomes. Here we describe an integrated set of eight structural variant classes comprising both balanced and unbalanced variants, which we constructed using short-read DNA sequencing data and statistically phased onto haplotype blocks in 26 human populations. Analysing this set, we identify numerous gene-intersecting structural variants exhibiting population stratification and describe naturally occurring homozygous gene knockouts that suggest the dispensability of a variety of human genes. We demonstrate that structural variants are enriched on haplotypes identified by genome-wide association studies and exhibit enrichment for expression quantitative trait loci. Additionally, we uncover appreciable levels of structural variant complexity at different scales, including genic loci subject to clusters of repeated rearrangement and complex structural variants with multiple breakpoints likely to have formed through individual mutational events. Our catalogue will enhance future studies into structural variant demography, functional impact and disease association.

3 December 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AFAdam Frankish
Adam Frankish
MDMark Diekhans
Mark Diekhans
IJIrwin Jungreis
Irwin Jungreis
JLJulien Lagarde
Julien Lagarde
JLJane E Loveland
Jane E Loveland
PFPaul Flicek
Paul Flicek
The GENCODE project annotates human and mouse genes and transcripts supported by experimental data with high accuracy, providing a foundational resource that supports genome biology and clinical genomics. GENCODE annotation processes make use of primary data and bioinformatic tools and analysis generated both within the consortium and externally to support the creation of transcript structures and the determination of their function. Here, we present improvements to our annotation infrastructure, bioinformatics tools, and analysis, and the advances they support in the annotation of the human and mouse genomes including: the completion of first pass manual annotation for the mouse reference genome; targeted improvements to the annotation of genes associated with SARS-CoV-2 infection; collaborative projects to achieve convergence across reference annotation databases for the annotation of human and mouse protein-coding genes; and the first GENCODE manually supervised automated annotation of lncRNAs. Our annotation is accessible via Ensembl, the UCSC Genome Browser and https://www.gencodegenes.org.

1 August 2020 in GigaScience
Verified
Journal Article
Open access
PDF file
KFKunjie Fan
Kunjie Fan
YGYuanfang Guan
Yuanfang Guan
YZYan Zhang
Yan Zhang
Background: Identifying protein functions is important for many biological applications. Since experimental functional characterization of proteins is time-consuming and costly, accurate and efficient computational methods for predicting protein functions are in great demand for generating the testable hypotheses guiding large-scale experiments.“ Results: Here, we propose Graph2GO, a multi-modal graph-based representation learning model that can integrate heterogeneous information, including multiple types of interaction networks (sequence similarity network and protein-protein interaction network) and protein features (amino acid sequence, subcellular location, and protein domains) to predict protein functions on gene ontology. Comparing Graph2GO to BLAST, as a baseline model, and to two popular protein function prediction methods (Mashup and deepNF), we demonstrated that our model can achieve state-of-the-art performance. We show the robustness of our model by testing on multiple species. We also provide a web server supporting function query and downstream analysis on-the-fly. Conclusions: Graph2GO is the first model that has utilized attributed network representation learning methods to model both interaction networks and protein features for predicting protein functions, and achieved promising performance. Our model can be easily extended to include more protein features to further improve the performance. Besides, Graph2GO is also applicable to other application scenarios involving biological networks, and the learned latent representations can be used as feature inputs for machine learning tasks in various downstream analyses.

29 June 2017 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
YZYan Zhang
Yan Zhang
SLShantao Li
Shantao Li
AAAlexij Abyzov
Alexij Abyzov
MGMark B. Gerstein
Mark B. Gerstein
Retroduplications come from reverse transcription of mRNAs and their insertion back into the genome. Here, we performed comprehensive discovery and analysis of retroduplications in a large cohort of 2,535 individuals from 26 human populations, as part of 1000 Genomes Phase 3. We developed an integrated approach to discover novel retroduplications combining high-coverage exome and low-coverage whole-genome sequencing data, utilizing information from both exon-exon junctions and discordant paired-end reads. We found 503 parent genes having novel retroduplications absent from the reference genome. Based solely on retroduplication variation, we built phylogenetic trees of human populations; these represent superpopulation structure well and indicate that variable retroduplications are effective population markers. We further identified 43 retroduplication parent genes differentiating superpopulations. This group contains several interesting insertion events, including a SLMO2 retroduplication and insertion into CAV3, which has a potential disease association. We also found retroduplications to be associated with a variety of genomic features: (1) Insertion sites were correlated with regular nucleosome positioning. (2) They, predictably, tend to avoid conserved functional regions, such as exons, but, somewhat surprisingly, also avoid introns. (3) Retroduplications tend to be co-inserted with young L1 elements, indicating recent retrotranspositional activity, and (4) they have a weak tendency to originate from highly expressed parent genes. Our investigation provides insight into the functional impact and association with genomic elements of retroduplications. We anticipate our approach and analytical methodology to have application in a more clinical context, where exome sequencing data is abundant and the discovery of retroduplications can potentially improve the accuracy of SNP calling. We developed an approach and performed comprehensive discovery of retroduplications from 26 human populations, utilizing whole-exome and whole-genome sequencing data. Our high-resolution landscape of retroduplications reveals that variable retroduplications are effective markers of human populations and can track population divergence. We observed that novel retroduplications come from genes with relatively high expression level and co-inserted L1 elements belong to young L1 families, indicating recent retroduplication activity in human migration contributing to genetic diversity. We have also detected several interesting intragenic insertion events, including SLMO2 retroduplication and insertion into CAV3, which worth further investigation for disease predisposition.

26 April 2021 in Genome Medicine
Verified
Journal Article
Open access
PDF file
XLXiaotong Li
Xiaotong Li
SKSushant Kumar
Sushant Kumar
AHArif Ozgun Harmanci
Arif Ozgun Harmanci
SLShantao Li
Shantao Li
RKRobert R. Kitchen
Robert R. Kitchen
MGMark Gerstein
Mark Gerstein
Background: Inflammatory breast cancer (IBC) has a highly invasive and metastatic phenotype. However, little is known about its genetic drivers. To address this, we report the largest cohort of whole-genome sequencing (WGS) of IBC cases. Methods: We performed WGS of 20 IBC samples and paired normal blood DNA to identify genomic alterations. For comparison, we used 23 matched non-IBC samples from the Cancer Genome Atlas Program (TCGA). We also validated our findings using WGS data from the International Cancer Genome Consortium (ICGC) and the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium. We examined a wide selection of genomic features to search for differences between IBC and conventional breast cancer. These include (i) somatic and germline single-nucleotide variants (SNVs), in both coding and non-coding regions; (ii) the mutational signature and the clonal architecture derived from these SNVs; (iii) copy number and structural variants (CNVs and SVs); and (iv) non-human sequence in the tumors (i.e., exogenous sequences of bacterial origin). Results: Overall, IBC has similar genomic characteristics to non-IBC, including specific alterations, overall mutational load and signature, and tumor heterogeneity. In particular, we observed similar mutation frequencies between IBC and non-IBC, for each gene and most cancer-related pathways. Moreover, we found no exogenous sequences of infectious agents specific to IBC samples. Even though we could not find any strongly statistically distinguishing genomic features between the two groups, we did find some suggestive differences in IBC: (i) The MAST2 gene was more frequently mutated (20% IBC vs. 0% non-IBC). (ii) The TGF β pathway was more frequently disrupted by germline SNVs (50% vs. 13%). (iii) Different copy number profiles were observed in several genomic regions harboring cancer genes. (iv) Complex SVs were more frequent. (v) The clonal architecture was simpler, suggesting more homogenous tumor-evolutionary lineages. Conclusions: Whole-genome sequencing of IBC manifests a similar genomic architecture to non-IBC. We found no unique genomic alterations shared in just IBCs; however, subtle genomic differences were observed including germline alterations in TGFβ pathway genes and somatic mutations in the MAST2 kinase that could represent potential therapeutic targets.

26 April 2019 in GigaScience
Verified
Journal Article
Open access
PDF file
TJTravis S Johnson
Travis S Johnson
SLSihong Li
Sihong Li
EFEric Franz
Eric Franz
ZHZhi Huang
Zhi Huang
SLShuyu Dan Li
Shuyu Dan Li
YZYan Zhang
Yan Zhang
Long thought “relics” of evolution, not until recently have pseudogenes been of medical interest regarding regulation in cancer. Often, these regulatory roles are a direct by-product of their close sequence homology to protein-coding genes. Novel pseudogene-gene (PGG) functional associations can be identified through the integration of biomedical data, such as sequence homology, functional pathways, gene expression, pseudogene expression, and microRNA expression. However, not all of the information has been integrated, and almost all previous pseudogene studies relied on 1:1 pseudogene–parent gene relationships without leveraging other homologous genes/pseudogenes. We produce PGG families that expand beyond the current 1:1 paradigm. First, we construct expansive PGG databases by (i) CUDAlign graphics processing unit (GPU) accelerated local alignment of all pseudogenes to gene families (totaling 1.6 billion individual local alignments and >40,000 GPU hours) and (ii) BLAST-based assignment of pseudogenes to gene families. Second, we create an open-source web application (PseudoFuN [Pseudogene Functional Networks]) to search for integrative functional relationships of sequence homology, microRNA expression, gene expression, pseudogene expression, and gene ontology. We produce four “flavors” of CUDAlign-based databases (>462,000,000 PGG pairwise alignments and 133,770 PGG families) that can be queried and downloaded using PseudoFuN. These databases are consistent with previous 1:1 PGG annotation and also are much more powerful including millions of de novo PGG associations. For example, we find multiple known (e.g., miR-20a-PTEN-PTENP1) and novel (e.g., miR-375-SOX15-PPP4R1L) microRNA-gene-pseudogene associations in prostate cancer. PseudoFuN provides a “one stop shop” for identifying and visualizing thousands of potential regulatory relationships related to pseudogenes in The Cancer Genome Atlas cancers. Thousands of new PGG associations can be explored in the context of microRNA-gene-pseudogene co-expression and differential expression with a simple-to-use online tool by bioinformaticians and oncologists alike.